EWD-16138-41954
5 vaccinations
12 coded responses
57 check-ins
11 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 430 / OH
- Registered
- 2021-02-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-17
Registered in v-safe
-
2021-02-17
Dose 1 — Pfizer-BioNTech
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
-
2021-02-21
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Fair · Fatigue or tirednessFree text: Chemo patientMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-03-03
-
2021-03-10
Dose 2 — Pfizer-BioNTech
- 2021-03-10
-
2021-03-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-03-16
Survey response — days 1–6 daily, dose 2MedDRA: Chemotherapy, Pre-existing disease — Feeling: Good · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Last Chemo Feb 18, 2021MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-17
- 2021-03-24
-
2021-03-31
Survey response — day 21, dose 2MedDRA: Injection site pain, Injection site swelling — Feeling: GoodFree text: Pain and swelling below injection site. No rednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-06-09
-
2021-08-18
Dose 3 — Pfizer-BioNTech
-
2021-08-18
Survey response — day 0, dose 3MedDRA: Unevaluable event — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Chemotherapy patient thus todays symptomsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-19
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-23
Survey response — days 1–6 daily, dose 3MedDRA: Unevaluable event — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Chemotherapy ptobablyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-24
Survey response — days 1–6 daily, dose 3MedDRA: Unevaluable event — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: ChemotherapyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-25
Health check-in — day 7, dose 3Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-01
- 2021-09-08
- 2021-09-15
- 2021-09-22
-
2021-09-29
Survey response — day 42, dose 3MedDRA: Blood pressure increased, Chemotherapy, Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: On oral Chemo Lynparza, and my BP has elevated to 190/107. Feeling very tired and headache. Starting addtl anti-hypertensive.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-29
Report sent to call center — day 42, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-04
- 2021-11-17
- 2022-02-16
-
2022-04-11
Dose 4 — Pfizer-BioNTech
-
2022-04-12
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-13
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-14
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · None · Be unable to do your normal daily activitiesAdult check-in
- 2022-04-15
- 2022-04-16
- 2022-04-17
- 2022-04-18
- 2022-04-25
-
2022-05-02
Survey response — day 21, dose 4MedDRA: Unevaluable event — Feeling: Fair · Be unable to do your normal daily activitiesFree text: ChemotherapyMedDRA releases: 2024-11 · check-in free text available
- 2022-05-09
- 2022-05-16
- 2022-05-23
- 2022-07-11
-
2022-09-07
Dose 5 — Moderna
-
2022-10-01
Survey response — day 21, dose 5MedDRA: Adverse drug reaction, Chemotherapy, Ovarian cancer — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Pulmonary Embolism related to Ovarian Cancer and ChemoMedDRA releases: 2024-11 · check-in free text available
-
2022-10-01
Report sent to call center — day 21, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2022-10-03
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-03
Call successfulParticipant prefers to complete VAERS report online
- 2022-10-05
-
2022-10-13
Survey response — day 35, dose 5MedDRA: Fatigue, Headache, Myalgia, Nausea, Oropharyngeal pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sore throat, muscle pain, headache, nausea and fatigue lasting 2 weeksMedDRA releases: 2024-11 · check-in free text available
- 2022-10-19
-
2022-12-07
Survey response — 3 months, dose 5MedDRA: Office visit, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Reactivation of Epstein-Barr Virus about 3 weeks after Bivalent booster. · Healthcare visit (other): Saw primary care MDMedDRA releases: 2024-11 · check-in free text available
-
2022-12-07
Report sent to call center — 3 months, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-12-08
-
2023-03-08
Survey response — 6 months, dose 5MedDRA: Eczema, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-03-08
Report sent to call center — 6 months, dose 5Get care from a doctor or other healthcare professional1 call case(s)
-
2023-03-09
Call successfulReported to VAERS during previous contact from GDIT
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-17 | Pfizer-BioNTech | |
| 2 | 2021-03-10 | Pfizer-BioNTech | |
| 3 | 2021-08-18 | Pfizer-BioNTech | No |
| 4 | 2022-04-11 | Pfizer-BioNTech | No |
| 5 | 2022-09-07 | Moderna | No |
Call center
4 call center cases
4 successful
VAERS report filed, before or during a call: 2
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Chemo patient
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Last Chemo Feb 18, 2021
Release 6 — day 21, dose 2
Symptoms: Pain and swelling below injection site. No redness
Release 9 — day 0, dose 3
Systemic reaction (other): Chemotherapy patient thus todays symptoms
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Chemotherapy ptobably
Systemic reaction (other): Chemotherapy
Release 9 — day 42, dose 3
Symptoms: On oral Chemo Lynparza, and my BP has elevated to 190/107. Feeling very tired and headache. Starting addtl anti-hypertensive.
Release 11 — day 21, dose 4
Symptoms: Chemotherapy
Release 12 — day 21, dose 5
Symptoms: Pulmonary Embolism related to Ovarian Cancer and Chemo
Release 12 — day 35, dose 5
Symptoms: Sore throat, muscle pain, headache, nausea and fatigue lasting 2 weeks
Release 12 — 3 months, dose 5
Symptoms: Reactivation of Epstein-Barr Virus about 3 weeks after Bivalent booster.
Healthcare visit (other): Saw primary care MD
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Adverse drug reaction | · | · | ✓ |
| SD | Blood pressure increased | · | · | ✓ |
| SD | Chemotherapy | · | · | ✓ |
| SD | Eczema | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Ovarian cancer | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Chemotherapy | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release